Search - tctmd.com

Displaying 701 - 720 of 6141

Sort: Relevancy | Date

Presentation TCT 2024

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Presenter: Pamela Ropski

October 29, 2024

Presentation TCT 2024

TCT 599: The Prognostic Role of a Novel Computational Approach Assessing Microcirculatory Resistance Based on a Single Angiographic View in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Yang Chen

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

Presenter: Ricky E Lemus-Zamora

October 29, 2024

Presentation TCT 2024

TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

October 29, 2024

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Bruce Adrian Casipit

October 29, 2024

Presentation TCT 2024

TCT 131: In-Hospital, 1-Year and Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Permanent Pacemaker Implantation

Presenter: Sindhuja Palle

October 29, 2024

Presentation TCT 2024

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

Presenter: Pieter Smits

October 29, 2024

Presentation TCT 2024

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Usman Akbar

October 29, 2024

Presentation TCT 2024

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

Presenter: Eric Rytkin

October 29, 2024

Presentation TCT 2024

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Presenter: Tobias Rheude

October 29, 2024

Presentation TCT 2024

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Presenter: Thomas Pilgrim

October 29, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

Presentation TCT 2024

Case: Rising Gradients Soon After TAVR

Presenter: Mahesh Madhavan

October 28, 2024

Presentation TCT 2024

Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve

Presenter: Ron Waksman

October 28, 2024

Presentation TCT 2024

Comparative Data of Valve Performance Between Latest Generation Intra-Annular Versus Supra-Annular Self-Expandable Transcatheter Heart Valves in Small Aortic Annuli

Presenter: Masahiko Asami

October 28, 2024

Presentation TCT 2024

Post-TAVR Risk-Stratification for Conduction Disturbances

Presenter: Shmuel Chen

October 28, 2024

Presentation TCT 2024

Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR

Presenter: Amit Vora

October 28, 2024

Advertisement

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

TCT 599: The Prognostic Role of a Novel Computational Approach Assessing Microcirculatory Resistance Based on a Single Angiographic View in Patients Undergoing Transcatheter Aortic Valve Replacement

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

TCT 131: In-Hospital, 1-Year and Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Permanent Pacemaker Implantation

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Case: Rising Gradients Soon After TAVR

Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve

Comparative Data of Valve Performance Between Latest Generation Intra-Annular Versus Supra-Annular Self-Expandable Transcatheter Heart Valves in Small Aortic Annuli

Post-TAVR Risk-Stratification for Conduction Disturbances

Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content